Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder

ClinicalTrials.gov ID: NCT01629966

Public ClinicalTrials.gov record NCT01629966. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 7:40 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-blind, Placebo-Controlled Fixed-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy, safety and tolerability of vilazodone relative to placebo in the treatment of generalized anxiety disorder (GAD)

Study identification

NCT ID
NCT01629966
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Forest Laboratories
Industry
Enrollment
680 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2012 (Actual)
Primary completion
Feb 28, 2014 (Actual)
Completion
Mar 31, 2014 (Actual)
Last update posted
Dec 18, 2019

2012 – 2014

United States locations

U.S. sites
37
U.S. states
23
U.S. cities
34
Facility City State ZIP Site status
Forest Investigative Site 001 Birmingham Alabama 35216 —
Forest Investigative Site 021 Beverly Hills California 90210 —
Forest Investigative Site 023 Glendale California 91204 —
Forest Investigative Site 011 Paramount California 90723 —
Forest Investigative Site 026 Norwich Connecticut 06360 —
Forest Investigative Site 027 Waterbury Connecticut 06708 —
Forest Investigative Site 005 Delray Beach Florida 33484 —
Forest Investigative Site 014 Oakland Park Florida 33334 —
Forest Investigative Site 019 South Miami Florida 33143 —
Forest Investigative Site 038 Atlanta Georgia 30328 —
Forest Investigative Site 035 Decatur Georgia 30030 —
Forest Investigative Site 028 Chicago Illinois 60634 —
Forest Investigative Site 030 Schaumburg Illinois 60194 —
Forest Investigative Site 029 Topeka Kansas 66606 —
Forest Investigative Site 033 Wichita Kansas 67207 —
Forest Investigative Site 010 Lake Charles Louisiana 70629 —
Forest Investigative Site 031 Baltimore Maryland 21208 —
Forest Investigative Site 025 Boston Massachusetts 02114 —
Forest Investigative Site 037 St Louis Missouri 63104 —
Forest Investigative Site 015 Las Vegas Nevada 89103 —
Forest Investigative Site 016 Berlin New Jersey 08009 —
Forest Investigative Site 007 Brooklyn New York 11235 —
Forest Investigative Site 024 New York New York 10003 —
Forest Investigative Site 032 New York New York 10023 —
Forest Investigative Site 012 New York New York 10168 —
Forest Investigative Site 020 Bismarck North Dakota 58501 —
Forest Investigative Site 008 Cincinnati Ohio 45215 —
Forest Investigative Site 041 Dayton Ohio 45414 —
Forest Investigative Site 004 Oklahoma City Oklahoma 73112 —
Forest Investigative Site 034 Oklahoma City Oklahoma 73116 —
Forest Investigative Site 013 Portland Oregon 97210 —
Forest Investigative Site 006 Memphis Tennessee 38119 —
Forest Investigative Site 017 Wichita Falls Texas 76309 —
Forest Investigative Site 003 Salt Lake City Utah 84106 —
Forest Investigative Site 018 Charlottesville Virginia 22911 —
Forest Investigative Site 040 Bellevue Washington 98007 —
Forest Investigative Site 039 Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01629966, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 18, 2019 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01629966 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →